(NP (NP (NN Background)) (: :) (S (NP (NNS Children)) (VP (VBP are) (ADVP (RB frequently)) (VP (VBN prescribed) (NP (NN medication)) (ADVP (NN off-label)) (, ,) (S (VP (VBG meaning) (SBAR (S (NP (RB there)) (VP (VBZ has) (RB not) (VP (VBN been) (NP (NP (JJ sufficient) (NN testing)) (PP (IN of) (NP (DT the) (NN medication))) (SBAR (S (VP (TO to) (VP (VB determine) (NP (PRP$ its) (NN safety) (CC or) (NN effectiveness)))))))))))))))) (. .))
(S (NP (NP (DT The) (JJ main) (NN reason)) (SBAR (S (NP (DT this) (NN safety) (NN knowledge)) (VP (VBZ is) (VP (VBG lacking)))))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ ethical) (NNS restrictions)) (SBAR (WHNP (WDT that)) (S (VP (VBP prevent) (NP (NNS children)) (PP (IN from) (S (VP (VBG being) (VP (VBN included) (PP (IN in) (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ clinical) (NNS trials)))))))))))))))) (. .))
(NP (NP (NN Objective)) (: :) (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN paper)))) (VP (VBZ is) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (DT an) (NN ensemble)) (PP (IN of) (NP (JJ simple) (NN study) (NNS designs)))) (VP (MD can) (VP (VB be) (VP (VBN implemented) (S (VP (TO to) (VP (VB signal) (NP (ADJP (RB acutely) (VBG occurring)) (NN side) (NNS effects)) (ADVP (RB effectively)) (PP (IN within) (NP (DT the) (JJ paediatric) (NN population))) (PP (IN by) (S (VP (VBG using) (NP (JJ historical) (JJ longitudinal) (NNS data)))))))))))))))))) (. .))
(S (S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NN pharmacovigilance) (NNS techniques)))) (VP (VBP are) (ADJP (JJ unsupervised)))) (, ,) (CC but) (S (NP (DT this) (NN research)) (VP (VBZ presents) (NP (DT a) (JJ supervised) (NN framework)))) (. .))
(NP (NP (NNS Methods)) (: :) (S (S (NP (NP (JJ Multiple) (NNS measures)) (PP (IN of) (NP (NN association)))) (VP (VBP are) (VP (VBN calculated) (PP (IN for) (NP (DT each) (NN drug) (CC and) (JJ medical) (NN event) (NN pair)))))) (CC and) (S (NP (DT these)) (VP (VBP are) (VP (VBN used) (PP (IN as) (NP (NP (NNS features)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN fed) (PP (IN into) (NP (DT a) (NN classiffier))) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (S (NP (DT the) (NN drug) (CC and) (JJ medical) (NN event) (NN pair)) (VP (VBG corresponding) (PP (TO to) (NP (DT an) (JJ adverse) (NN drug) (NN reaction)))))))))))))))))))) (. .))
(S (NP (DT The) (NN classiffier)) (VP (VBZ is) (VP (VBN trained) (S (VP (VBG using) (NP (NP (JJ known) (JJ adverse) (NN drug) (NNS reactions)) (CC or) (NP (VBN known) (JJ non-adverse) (NN drug) (NN reaction) (NNS relationships))))))) (. .))
(NP (NP (NNS Results)) (: :) (S (NP (DT The) (NN novel) (JJ ensemble) (NN framework)) (VP (VBD obtained) (NP (NP (NP (DT a) (JJ false) (JJ positive) (NN rate)) (PP (IN of) (NP (CD 0:149)))) (, ,) (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (CD 0:547)))) (CC and) (NP (NP (DT a) (NN specificity)) (PP (IN of) (NP (CD 0:851))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN implemented) (PP (IN on) (NP (NP (DT a) (NN reference) (NN set)) (PP (IN of) (NP (NN drug) (CC and) (JJ medical) (NN event) (NNS pairs)))))))))) (. .))
(S (NP (DT The) (JJ novel) (NN framework)) (VP (ADVP (RB consistently)) (VBD outperformed) (NP (DT each) (JJ individual) (NN simple) (NN study) (NN design))) (. .))
(NP (NP (NN Conclusion)) (: :) (S (NP (DT This) (NN research)) (VP (VP (VBZ shows) (SBAR (IN that) (S (NP (NP (PRP it))) (VP (VBZ is) (ADJP (JJ possible)) (S (VP (TO to) (VP (VB exploit) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN causality))))))))))) (CC and) (VP (VBZ presents) (NP (NP (DT a) (NN framework)) (PP (IN for) (S (VP (VBG signalling) (NP (JJ adverse) (NN drug) (NNS reactions)) (ADVP (RB effectively))))))))) (. .))
